Variables | Adhered | Non-Adhered | COR (95%) | AOR (95%) | P value | |
---|---|---|---|---|---|---|
Sex | Male Female | 103 (78.6%) 120 (64.3%) | 28 (21.4%) 65 (35.1%) | 1 0.502 (0.300–0.840) | 1 0.323 (0.164–0.637) * | 0.001* |
WHO stage at start of ART | Stage 1 Stage 2 Stage 3 Stage 4 | 82 (79.6%) 70 (71.4%) 56 (67.5%) 15 (46.9%) | 21 (20.4%) 28 (28.6%) 27 (32.5%) 17 (53.1%) | 1 0.640 (0.334–1.226) 0.531 (0.273–1.032) 0.226 (0.097–0.525) | 1 1.117 (0.480–2.598) 0.881 (0.374–2.073) 0.386 (0.142–1.052) | 0.797 0.771 0.063 |
History of opportunistic Infection | Yes | 57 (57.0%) | 43 (43.0%) | 0.394 (0.237–0.654) | 0.483 (0.249–0.936) * | 0.031* |
Additional medication | Yes | 31 (47.7%) | 34 (52.3%) | 0.280 (0.159–0.494) | 0.436 (0.206–0.922) * | 0.030* |
Availability of service in the facility | Yes | 68 (75.6%) | 22 (24.4%) | 1.416 (0.811–2.471) | 2.206 (1.031–4.721) * | 0.042* |